vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and SHENANDOAH TELECOMMUNICATIONS CO (SHEN). Click either name above to swap in a different company.

SHENANDOAH TELECOMMUNICATIONS CO is the larger business by last-quarter revenue ($91.6M vs $77.6M, roughly 1.2× Bioceres Crop Solutions Corp.). SHENANDOAH TELECOMMUNICATIONS CO runs the higher net margin — -5.9% vs -9.6%, a 3.7% gap on every dollar of revenue. On growth, SHENANDOAH TELECOMMUNICATIONS CO posted the faster year-over-year revenue change (7.2% vs -16.8%). Over the past eight quarters, SHENANDOAH TELECOMMUNICATIONS CO's revenue compounded faster (15.0% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Shenandoah Telecommunications Co is a U.S. regional telecom provider offering broadband internet, wireless voice/data services, digital cable TV, and fiber-optic solutions. It serves residential, small business and enterprise clients across Mid-Atlantic states, focusing on underserved rural and suburban markets in Virginia, West Virginia, Maryland and Pennsylvania.

BIOX vs SHEN — Head-to-Head

Bigger by revenue
SHEN
SHEN
1.2× larger
SHEN
$91.6M
$77.6M
BIOX
Growing faster (revenue YoY)
SHEN
SHEN
+24.1% gap
SHEN
7.2%
-16.8%
BIOX
Higher net margin
SHEN
SHEN
3.7% more per $
SHEN
-5.9%
-9.6%
BIOX
Faster 2-yr revenue CAGR
SHEN
SHEN
Annualised
SHEN
15.0%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
SHEN
SHEN
Revenue
$77.6M
$91.6M
Net Profit
$-7.4M
$-5.4M
Gross Margin
46.8%
Operating Margin
9.3%
-1.0%
Net Margin
-9.6%
-5.9%
Revenue YoY
-16.8%
7.2%
Net Profit YoY
-20.2%
-95.8%
EPS (diluted)
$-0.12
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
SHEN
SHEN
Q4 25
$91.6M
Q3 25
$77.6M
$89.8M
Q2 25
$88.6M
Q1 25
$60.6M
$87.9M
Q4 24
$98.8M
$85.4M
Q3 24
$93.3M
$87.6M
Q2 24
$85.8M
Q1 24
$84.0M
$69.2M
Net Profit
BIOX
BIOX
SHEN
SHEN
Q4 25
$-5.4M
Q3 25
$-7.4M
$-9.4M
Q2 25
$-9.0M
Q1 25
$-1.6M
$-9.1M
Q4 24
$605.2K
$-2.7M
Q3 24
$-6.2M
$-5.3M
Q2 24
$-12.9M
Q1 24
$9.8M
$214.7M
Gross Margin
BIOX
BIOX
SHEN
SHEN
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
SHEN
SHEN
Q4 25
-1.0%
Q3 25
9.3%
-8.0%
Q2 25
-10.3%
Q1 25
1.5%
-6.9%
Q4 24
14.5%
-6.7%
Q3 24
2.5%
-4.8%
Q2 24
-18.5%
Q1 24
15.7%
-4.0%
Net Margin
BIOX
BIOX
SHEN
SHEN
Q4 25
-5.9%
Q3 25
-9.6%
-10.5%
Q2 25
-10.2%
Q1 25
-2.6%
-10.4%
Q4 24
0.6%
-3.2%
Q3 24
-6.6%
-6.0%
Q2 24
-15.0%
Q1 24
11.6%
310.0%
EPS (diluted)
BIOX
BIOX
SHEN
SHEN
Q4 25
$-0.13
Q3 25
$-0.12
$-0.20
Q2 25
$-0.19
Q1 25
$-0.02
$-0.19
Q4 24
$0.00
$-0.34
Q3 24
$-0.10
$-0.13
Q2 24
$-0.24
Q1 24
$0.14
$4.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
SHEN
SHEN
Cash + ST InvestmentsLiquidity on hand
$15.5M
$27.3M
Total DebtLower is stronger
$642.4M
Stockholders' EquityBook value
$288.3M
$880.8M
Total Assets
$734.9M
$1.9B
Debt / EquityLower = less leverage
0.73×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
SHEN
SHEN
Q4 25
$27.3M
Q3 25
$15.5M
$22.6M
Q2 25
$29.1M
Q1 25
$38.5M
$87.5M
Q4 24
$29.2M
$46.3M
Q3 24
$32.3M
$43.1M
Q2 24
$43.8M
Q1 24
$16.4M
$389.7M
Total Debt
BIOX
BIOX
SHEN
SHEN
Q4 25
$642.4M
Q3 25
$535.4M
Q2 25
$513.1M
Q1 25
$515.8M
Q4 24
$418.0M
Q3 24
$345.2M
Q2 24
$297.4M
Q1 24
$298.7M
Stockholders' Equity
BIOX
BIOX
SHEN
SHEN
Q4 25
$880.8M
Q3 25
$288.3M
$892.7M
Q2 25
$902.0M
Q1 25
$345.0M
$910.5M
Q4 24
$346.3M
$918.6M
Q3 24
$346.0M
$925.4M
Q2 24
$933.1M
Q1 24
$348.5M
$871.6M
Total Assets
BIOX
BIOX
SHEN
SHEN
Q4 25
$1.9B
Q3 25
$734.9M
$1.9B
Q2 25
$1.8B
Q1 25
$798.2M
$1.8B
Q4 24
$835.2M
$1.7B
Q3 24
$827.3M
$1.7B
Q2 24
$1.7B
Q1 24
$836.1M
$1.4B
Debt / Equity
BIOX
BIOX
SHEN
SHEN
Q4 25
0.73×
Q3 25
0.60×
Q2 25
0.57×
Q1 25
0.57×
Q4 24
0.46×
Q3 24
0.37×
Q2 24
0.32×
Q1 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
SHEN
SHEN
Operating Cash FlowLast quarter
$14.4M
$28.8M
Free Cash FlowOCF − Capex
$-78.6M
FCF MarginFCF / Revenue
-85.8%
Capex IntensityCapex / Revenue
117.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-257.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
SHEN
SHEN
Q4 25
$28.8M
Q3 25
$14.4M
$30.7M
Q2 25
$20.9M
Q1 25
$23.3M
$20.5M
Q4 24
$-5.4M
$20.6M
Q3 24
$5.2M
$24.3M
Q2 24
$2.5M
Q1 24
$-17.4M
$15.2M
Free Cash Flow
BIOX
BIOX
SHEN
SHEN
Q4 25
$-78.6M
Q3 25
$-51.4M
Q2 25
$-65.3M
Q1 25
$-62.7M
Q4 24
$-72.0M
Q3 24
$-51.3M
Q2 24
$-78.3M
Q1 24
$-54.9M
FCF Margin
BIOX
BIOX
SHEN
SHEN
Q4 25
-85.8%
Q3 25
-57.2%
Q2 25
-73.7%
Q1 25
-71.3%
Q4 24
-84.3%
Q3 24
-58.5%
Q2 24
-91.3%
Q1 24
-79.3%
Capex Intensity
BIOX
BIOX
SHEN
SHEN
Q4 25
117.2%
Q3 25
91.4%
Q2 25
97.3%
Q1 25
94.7%
Q4 24
108.4%
Q3 24
86.2%
Q2 24
94.2%
Q1 24
101.2%
Cash Conversion
BIOX
BIOX
SHEN
SHEN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
Q1 24
-1.78×
0.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

SHEN
SHEN

Residential And SMB Incumbent Broadband$41.5M45%
Residential And SMB Glo Fiber Expansion Markets$23.0M25%
Commercial Fiber$20.3M22%
RLEC Other$6.8M7%

Related Comparisons